Table 1 Fibrinogen levels, fibrinogen γ′... | American Society of Hematology

Table 1

Fibrinogen levels, fibrinogen γ′ levels, and fibrinogen γ′/fibrinogen ratios in healthy controls and patients with various cardiovascular diseases

Group	n	Fibrinogen, g/L	Fibrinogen γ′, g/L	Fibrinogen γ′/ total fibrinogen ratio	P*	P†
Population controls	173	3.30 (0.59)	0.33 (0.10)	0.10 (0.03)
Patients
Ischemic stroke (IS)	53	3.87 (1.19)	0.49 (0.18)	0.13 (0.02)	< .001
Pulmonary embolism (PE)						.54
Nonacute phase	13	2.69 (1.42)	0.53 (0.27)	0.20 (0.06)	< .001
Acute phase	16	4.39 (2.30)	0.79 (0.33)	0.24 (0.19)	< .001
Unstable angina pectoris (UAP)						.59
Stabilized	130	3.36 (0.76)	0.46 (0.15)	0.14 (0.04)	< .001
Refractory	72	3.82 (1.00)	0.53 (0.23)	0.14 (0.04)	< .001

Group	n	Fibrinogen, g/L	Fibrinogen γ′, g/L	Fibrinogen γ′/ total fibrinogen ratio	P*	P†
Population controls	173	3.30 (0.59)	0.33 (0.10)	0.10 (0.03)
Patients
Ischemic stroke (IS)	53	3.87 (1.19)	0.49 (0.18)	0.13 (0.02)	< .001
Pulmonary embolism (PE)						.54
Nonacute phase	13	2.69 (1.42)	0.53 (0.27)	0.20 (0.06)	< .001
Acute phase	16	4.39 (2.30)	0.79 (0.33)	0.24 (0.19)	< .001
Unstable angina pectoris (UAP)						.59
Stabilized	130	3.36 (0.76)	0.46 (0.15)	0.14 (0.04)	< .001
Refractory	72	3.82 (1.00)	0.53 (0.23)	0.14 (0.04)	< .001

Data presented are means (SD).

P value of fibrinogen γ′/total fibrinogen ratio between patients and healthy controls after adjustment for age and sex.

P value of fibrinogen γ′/total fibrinogen ratio between patient groups after adjustment for age and sex.